BDRX — Biodexa Pharmaceuticals Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT HALT NEWS PENDING AT 09:29 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ RESUMED AT 11:43 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 11:38 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
NASDAQ RESUMED AT 10:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:00 AM
NASDAQ RESUMED AT 09:39 AM
Brief: Biodexa Announces Partnership With Syngene To Manufacture Mtx240 Gmp Clinical Trial Supplies
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
Brief: Biodexa Pharmaceuticals Announces American Depositary Receipts Ratio Change
Brief: Biodexa Announces Exclusive License Of Otsuka’S Opb-171775, A Potent Phase 1 Ready Molecular Glue For Gist
Brief: Biodexa Pharmaceuticals Promotes Fiona Sharp To CFO
Brief: Biodexa Announces Pricing Of $10 Million Public Offering
NASDAQ RESUMED AT 09:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM